Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3.
Adie ViljoenKevin M PantaloneRodolfo J GalindoXuewei CuiRuth HuhAndrea HemmingwayLaura Fernández LandóHiren PatelPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
NCT03987919; NCT03882970.